Techcyte, a provider of AI-powered digital diagnostics for pathology, has announced a collaboration with Modella AI, a biomedical AI company. This ...
Artera, a leader in precision oncology, has received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its ArteraAI Prosta...
Reprieve Cardiovascular has raised $61 million in Series B funding to support the FASTR II pivotal clinical trial for its Reprieve system, designed...
The lipolysis laser market is experiencing significant growth, driven by advancements in minimally invasive fat reduction and body contouring techn...
Reprieve Cardiovascular, Inc., a clinical-stage company based in Milford, Massachusetts, has successfully closed a $61 million Series B financing r...
Teal Health has launched the Teal Wand, the first at-home cervical cancer screening device in the U.S. The device allows individuals to collect vag...
The Pharmacogenomics Market is experiencing transformative growth driven by the rise of personalized medicine, which tailors drug therapies based o...
Insmed has received approval from the Food and Drug Administration (FDA) for its new drug, Brensocatib, which is designed to treat bronchiectasis, ...
By Marie Mannes STOCKHOLM (Reuters) -Europe's car exporters are still struggling with uncertainty over U.S. tariffs despite last month's trade deal...
Bayer has announced a partnership with Kumquat Biosciences to develop a KRAS G12D inhibitor, a promising treatment for pancreatic, colorectal, and ...